Nisa Investment Advisors
SRNE

Nisa Investment Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Nisa Investment Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,886
Closed -$1K – 2920
2023
Q1 		$1K Sell
2,886
-200
-6% -$179 ﹤0.01% 2507
2022
Q4 		$3K Sell
3,086
-10,900
-78% -$14.5K ﹤0.01% 2355
2022
Q3 		$22K Hold
13,986
– – ﹤0.01% 2033
2022
Q2 		$28K Sell
13,986
-102,304
-88% -$177K ﹤0.01% 1946
2022
Q1 		$271K Buy
116,290
+113,090
+3,534% +$353K ﹤0.01% 1262
2021
Q4 		$11K Sell
3,200
-255,250
-99% -$1.58M ﹤0.01% 2024
2021
Q3 		$1.97M Hold
258,450
– – 0.01% 705
2021
Q2 		$2.5M Buy
258,450
+250,000
+2,959% +$1.99M 0.02% 661
2021
Q1 		$70K Sell
8,450
-750
-8% -$7.92K ﹤0.01% 1900
2020
Q4 		$63K Sell
9,200
-8,850
-49% -$71.1K ﹤0.01% 1924
2020
Q3 		$201K Buy
18,050
+16,350
+962% +$150K ﹤0.01% 1303
2020
Q2 		$11K Sell
1,700
-140
-8% -$536 ﹤0.01% 1909
2020
Q1 		$3K Buy
+1,840
New +$5.3K ﹤0.01% 2032

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Nisa Investment Advisors's SRNE Position: Q2 2023 in Review

Nisa Investment Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 2,886 shares — an estimated $1K sold.

Nisa Investment Advisors first reported a position in SRNE in Q1 2020 and held it in 13 quarters. The position peaked at $2.5M in Q2 2021. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

  • Nisa Investment Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 2,886 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $1K.
  • Nisa Investment Advisors first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 13 quarters.
  • Nisa Investment Advisors's Sorrento Therapeutics, Inc. position peaked at $2.5M in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Nisa Investment Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.